Literature DB >> 8839672

Pharmacokinetics of oxamniquine in rabbit and rat.

G O Kokwaro1, A A Indalo, G Taylor.   

Abstract

The pharmacokinetics of the schistosomicidal agent oxamniquine (6-hydroxmethyl-2-isopropylaminomethyl-7-nitro-1,2,3,4-tetra hydroquinoline) were studied in 8 (4 male, 4 female) New Zealand White rabbits and 5 female Wistar rats, following intravenous administration (15 mg/kg). The pharmacokinetic parameters (mean +/- SD) in the rabbit and rat, respectively, were as follows: plasma clearance, 65.5 +/- 33 and 17.2 +/- 5.7 ml/min/kg; steady-state volume of distribution, 7.9 +/- 4.5 and 2.1 +/- 0.5 l/kg; terminal elimination half-life, 1.8 +/- 0.3 and 1.8 +/- 0.9 h. Oxamniquine appeared to be widely distributed in both species, although significantly higher in the rabbit. Similarly, plasma clearance was significantly higher in the rabbit. Using reported estimates of liver blood flow and fractions excreted unchanged in urine of the rabbit and rat, calculations based on blood clearances indicated that oxamniquine has a low hepatic extraction ratio (0.2) in the rat and an intermediate hepatic extraction ratio (0.6) in the rabbit. From separate experiments, however, hepatic extraction appeared to be low in the rabbit, suggesting that oxamniquine disposition is probably broadly similar in both rabbit and rat.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8839672     DOI: 10.1007/BF03190272

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  8 in total

1.  Pharmacokinetic studies on praziquantel and oxamniquine in intestinal schistosomiasis.

Authors:  A Massoud; A S Hafez; M M Hussein; A H Abdel Karim; A el Nahaal
Journal:  J Egypt Soc Parasitol       Date:  1984-12

2.  A rapid, universal TI-59 model-independent pharmacokinetic analysis program based on statistical moment theory.

Authors:  D P Reitberg; I L Smith; S J Love; H M Lewin; J J Schentag
Journal:  Drug Intell Clin Pharm       Date:  1985-02

3.  Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics.

Authors:  H Boxenbaum
Journal:  J Pharmacokinet Biopharm       Date:  1982-04

4.  Sepcies differences in N-dealkylation of oxamniquine.

Authors:  N M Woolhouse; B Kaye; D V Parke
Journal:  Xenobiotica       Date:  1979-05       Impact factor: 1.908

5.  Partitioning of oxaminiquine into brain tissue following intravenous administration to female Wistar rats.

Authors:  G O Kokwaro; G Taylor
Journal:  Drug Chem Toxicol       Date:  1990       Impact factor: 3.356

6.  The metabolism of oxamniquine - a new schistosomicide.

Authors:  B Kaye; N M Woolhouse
Journal:  Ann Trop Med Parasitol       Date:  1976-09

7.  Seizures and electroencephalograph changes associated with oxamniquine therapy.

Authors:  J S Keystone
Journal:  Am J Trop Med Hyg       Date:  1978-03       Impact factor: 2.345

Review 8.  Schistosome infections in humans: perspectives and recent findings. NIH conference.

Authors:  T E Nash; A W Cheever; E A Ottesen; J A Cook
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.